Skip to content
HowShorted

Bio-Path Holdings, Inc. short interest in 2019

In 2019, Bio-Path Holdings, Inc.'s disclosed short interest ran from 1.06% of shares outstanding on 15 Jan 2019 to 4.63% on 31 Dec 2019, a change of +3.57 percentage points. The year's high was 23.93% on 15 Mar 2019 and its low 1.06% on 15 Jan 2019, averaging 9.07% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.63 days on 13 Sep 2019. Full history: Bio-Path Holdings, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for Bio-Path Holdings, Inc. in 2019

2019 in figures

Start of year
1.06% (15 Jan 2019)
End of year
4.63% (31 Dec 2019)
Change
+3.57 pp
High
23.93% (15 Mar 2019)
Low
1.06% (15 Jan 2019)
Average
9.07%
Highest days to cover
4.63 (13 Sep 2019)
SEC filings marked
8

Every report in 2019

Bio-Path Holdings, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 20191.06%1.00
15 Mar 201923.93%1.00
29 Mar 201917.09%1.0010-K filed, results (8-K)
15 Apr 201915.14%1.00
30 Apr 201914.97%1.08
15 May 201911.98%1.2710-Q filed
31 May 201911.75%2.09results (8-K)
14 Jun 201910.55%1.37
28 Jun 20198.26%3.56
15 Jul 20199.37%1.13
31 Jul 20199.85%1.00
15 Aug 20198.87%3.1210-Q filed, results (8-K)
30 Aug 20198.08%3.07
13 Sep 20196.83%4.63
30 Sep 20196.28%2.89
15 Oct 20194.53%2.06
31 Oct 20194.88%1.96
15 Nov 20192.87%1.5610-Q filed, results (8-K)
29 Nov 20195.02%1.00
13 Dec 20194.62%1.00
31 Dec 20194.63%1.09

See also: Bio-Path Holdings, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.